Delivery Order SPE2DB24D1006-SPE2DB25FCEPJ
- Not listed
- The Defense Logistics Agency awarded a $17,849.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) with an ultimate completion date of June 24, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,863.71 to AmerisourceBergen Drug Corp for OJJAARA 150 mg tablets in 30-tablet units, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors and...
- The Defense Logistics Agency awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 MG tablets in quantities of 30 units, with an ultimate completion date of October 14, 2025. The contract was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count unit doses. This firm fixed-price delivery order, issued on October 24, 2025, with completion scheduled for November 17, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $17,281.01 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count packages on November 17, 2025. This firm fixed-price delivery order, with a completion date of December 9, 2025, carries no set-aside designation and represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for OJJAARA 200 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $35,699.72, represents a competitive award with no set-aside designation and is scheduled for completion by October 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp on September 26, 2025, for supply of Ojjaara 200 mg tablets in 30-count units. This firm fixed price contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order was competitively awarded with no...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEPJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units. This non-competitive, firm fixed-price delivery order was awarded on April 30, 2025, with an ultimate completion date of May 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a primary supplier for the Defense Logistics Agency's medical supply chain, supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards with DLA have been competitively awarded without set-aside designations, reflecting the company's demonstrated capability to meet federal procurement requirements in open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 4/30/25 |